David Shaw’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19,800
Closed -$1.15M – 5275
2026
Q1
$1.15M Buy
+19,800
New +$912K ﹤0.01% 3343

Other funds holding XENE

David Shaw's XENE Position: Q3 2026 in Review

David Shaw reduced its Xenon Pharmaceuticals (XENE) stake by 86% in Q3 2026, selling an estimated $11.5M and leaving 30,243 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3693.

David Shaw first reported a position in XENE in Q4 2018 and has held it in 32 quarters since. The position peaked at $14.8M in Q4 2021. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • David Shaw held 30,243 shares of Xenon Pharmaceuticals worth $1.12M as of Q3 2026.
  • David Shaw sold 193,679 Xenon Pharmaceuticals shares in Q3 2026, an estimated $11.5M.
  • Xenon Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #3693 holding.
  • David Shaw first reported a position in Xenon Pharmaceuticals in Q4 2018 and has held it in 32 quarters since.
  • David Shaw's Xenon Pharmaceuticals position peaked at $14.8M in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.